• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Asia

Pharma

Carvykti, Sanofi, BeiGene—Fierce Pharma Asia

J&J and Legend's CAR-T hit its goal in a myeloma trial. Sanofi cuts hundreds of jobs in India. Tislelizumab's pre-approval inspections remain on hold.
Angus Liu Feb 3, 2023 8:25am

Takeda-Hutchmed, BeiGene, Astellas—Fierce Pharma Asia

Jan 27, 2023 8:25am

China's reimbursement talks, Sun, GenScript—Fierce Pharma Asia

Jan 20, 2023 9:00am

CRL inks pact to help develop liver cancer gene therapy

Jan 18, 2023 2:45pm

With big discounts, 100+ drugs win national coverage in China

Jan 18, 2023 2:30pm

Eisai, Astellas and Samsung Biologics—Fierce Pharma Asia

Jan 13, 2023 7:45am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy